Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Dana-Farber Cancer Institute Inc.
-
Notice | Filed: May 25, 2022 | Entered: May 25, 2022 Dana-Farber Cancer Institute, Inc. v. Bristol-Myers Squibb Co. et al
Contract: Other | Massachusetts
Notice of Appearance
NOTICE of Appearance by Thomas Lampert on behalf of Bristol-Myers Squibb Co., E.R. Squibb & Sons, LLC, Ono Pharmaceutical Co., Ltd. (Lampert, Thomas)
-
Order | Filed: May 18, 2022 | Entered: May 18, 2022 Novartis Pharmaceuticals Corporation et al v. Lotus Pharmaceutical Co., Ltd. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order
ORAL ORDER - Having reviewed the Amended Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) forms wherein the stay deadline has been updated to reflect the regulatory stay deadline (10/28/2024), IT IS HEREBY ORDERED that the bench trial in these matters will be held on 1/29/2024. The parties shall submit the revised proposed scheduling order (see the Court's 4/18/2022 Oral Order) on or before 6/1/2022. ORDERED by Judge Maryellen Noreika on 5/18/2022. (dlw)
-
Order | Filed: May 18, 2022 | Entered: May 18, 2022 Novartis Pharmaceuticals Corporation et al v. Dr. Reddys Laboratories, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order
ORAL ORDER - Having reviewed the Amended Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA) forms wherein the stay deadline has been updated to reflect the regulatory stay deadline (10/28/2024), IT IS HEREBY ORDERED that the bench trial in these matters will be held on 1/29/2024. The parties shall submit the revised proposed scheduling order (see the Court's 4/18/2022 Oral Order) on or before 6/1/2022. ORDERED by Judge Maryellen Noreika on 5/18/2022. (dlw)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login